---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-24-000002"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2024-01-04T23:59:59+00:00"
generated_at: "2026-06-07T03:58:11.473435+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "low"
source: SEC EDGAR
---

# Avanos Medical issues preliminary Q4/FY2023 results; no figures in filing

## Summary
- Announced selected unaudited preliminary results for Q4 and full year ended Dec 31, 2023.
- Press release furnished as Exhibit 99.1 but actual financial data is not included in filing text.
- No specific revenue, EPS, or guidance numbers disclosed in this 8-K.

## SEC filing metadata
- accession: 0001606498-24-000002
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2024-01-04T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000002/0001606498-24-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000002/avns-20240104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-24-000002
- JSON: https://secwatch.observer/filing/0001606498-24-000002.json
- Plain text: https://secwatch.observer/filing/0001606498-24-000002.txt

## Key facts
- Earnings Releases
  AVANOS MEDICAL, INC. reported preliminary financial results for the quarter and full-year ended December 31, 2023.
  - Period: the quarter and full-year ended December 31, 2023
  - Result: preliminary results
  source text: On January 4, 2024, Avanos Medical, Inc. (the “Company”) issued a press release that announced selected, unaudited preliminary financial results for the quarter and full-year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000002/0001606498-24-000002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.